Twenty-seven patients received acetyl-l-carnitine at a dose of 500 mg twice daily for 10 days intramuscularly followed by the oral intake of 500 mg for 50 days (arm A)
To view or add a comment, sign in 88% of self-funded employers face stop-loss claims annually, highlighting the prevalence of high-cost health events Learn about top health conditions, injectable drugs and strategies to improve employee wellbeing while controlling costs
NICE obesity guidance (CG189) does not include L-carnitine supplementation, and individuals seeking effective support are encouraged to speak with their GP about referral to appropriate NHS services
Patients who are pregnant or breastfeeding, have a history of medullary thyroid cancer or MEN-2 syndrome, severe gastroparesis, or certain pancreatic conditions may not be candidates
You may be closer to suitable if you have A small, localised pocket of fat under the chin (submental fat) Stable weight, and the fullness persists despite healthy lifestyle measures Good skin quality and elasticity, so the skin can tighten as volume reduces Realistic expectations, understanding results are gradual and vary You may be less suitable if the main issue is skin laxity If the double chin look is mainly due to loose skin, fat dissolving injections often give limited improvement